HALOZYME THERAPEUTICS, INC.
Venta netaHALO·US·🇺🇸 US
0%compras·100%ventas
9 transacciones$0Total compras·0 compras
$2.6MTotal ventas·4 ventas
22 insiders
Último: 2 abr 2026
| Fecha | Insider | Tipo | Valor | |
|---|---|---|---|---|
| 6 abr+1j | Torley HelenCEO·Option to Purchase Common Stock | EjercicioP | $121K | |
| 6 abr+1j | Torley HelenCEO·Common Stock | VentaP | $262K | |
| 6 abr+1j | Torley HelenCEO·Common Stock | VentaP | $373K | |
| 6 abr+1j | Torley HelenCEO·Common Stock | EjercicioP | $121K | |
| 2 abr+1j | Torley HelenCEO·Option to Purchase Common Stock | EjercicioP | $241K | |
| 2 abr+1j | Torley HelenCEO·Common Stock | VentaP | $273K | |
| 2 abr+1j | Torley HelenCEO·Common Stock | VentaP | $1.0M | |
| 2 abr+1j | Torley HelenCEO·Common Stock | EjercicioP | $241K | |
| 1 abr+2j | RAMSAY DAVID ACFO·Restricted Stock Units | Asignación | - | |
| 1 abr+2j | Torley HelenCEO·Option to Purchase Common Stock | EjercicioP | $241K | |
| 1 abr+2j | Torley HelenCEO·Common Stock | VentaP | $66K | |
| 1 abr+2j | Torley HelenCEO·Common Stock | VentaP | $1.2M | |
| 1 abr+2j | Torley HelenCEO·Common Stock | EjercicioP | $241K |